Aortic Regurgitation, Time to Aortic Valve Reintervention, and Mortality in Degenerated Trifecta Versus Non-Trifecta Bioprosthesis

The first Trifecta valve (Abbott, St Paul, Minnesota) was introduced in 2007, CE marked in 2010, and received US Food and Drug Administration (FDA) approval in 2011. An “improved” first-generation valve was introduced in 2015, with a second-generation Trifecta Glide Technology (GT) valve introduced in 2016 that received FDA approval the same year and with a new holder introduced with the later model in 2020. These stented valves touted a single bovine pericardi al tissue, externally mounted on a titanium stent that was designed for supra-annular placement.

Source: The American Journal of Cardiology - April 3, 2024 Category: Cardiology Authors: Amr E. Abbas, Luai Madanat, Houman Khalili, Ramy Mando, Mazhed Kheyrbek, Rohit Chandra, Shailesh Niroula, Ivan Hanson, Simon Dixon, Brian Renard, Richard Bloomingdale, Elvis Cami, Brittany Pridham, Jeffrey Altshuler, Bogdan Kindzelski, Franco Fazzalari, F Source Type: research